-+ 0.00%
-+ 0.00%
-+ 0.00%

Lee Chang-sun’s Aprogen Biologics Stake Falls to Zero From 16.95% After Convertible Bond Deal Cancellation

PUBT·10/26/2026 06:43:22
Listen to the news
Lee Chang-sun’s Aprogen Biologics Stake Falls to Zero From 16.95% After Convertible Bond Deal Cancellation
  • Leechangsun's reported holding in Aprogen Biologics fell to zero from 16.95%, a reduction of 3,262,642 share equivalents.
  • The change on Oct. 6, 2026, resulted from termination of a convertible bond purchase agreement.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Aprogen Biologics Inc. published the original content used to generate this news brief via DART, the regulatory disclosure system operated by the South Korea Financial Supervisory Service (FSS) (Ref. ID: 20261026000181), on October 26, 2026, and is solely responsible for the information contained therein.